Is this Europe’s most audacious founder?
Summary
Bertrand Duplat, co-founder and CEO of Robeautei, is developing tiny robots designed for the brain, a venture described as both difficult and audacious. His company, Robeautei, has successfully raised €18m in funding from prominent investors including Eurazeo, Bpifrance, and Omnes Capital. Duplat's approach emphasizes a long-term vision focused on fundamental research, aiming to solve complex, foundational problems rather than pursuing immediate commercial applications. He likens his work to building a "Dot" – a core innovation – rather than a "Line" of incremental progress. This strategy reflects a commitment to deep technological advancement in neuro-robotics, positioning Robeautei at the forefront of biomedical innovation.
Key takeaway
For investors evaluating early-stage deep tech, consider ventures like Robeautei that prioritize fundamental research over immediate commercialization. Your due diligence should assess the founder's audacious vision and long-term commitment to solving complex, foundational problems. This approach, though high-risk, can yield transformative breakthroughs, requiring patience and significant capital beyond typical short-term returns.
Key insights
Bertrand Duplat's Robeautei is pioneering tiny brain robots, driven by audacious, fundamental research and a long-term vision.
Principles
- Focus on fundamental, difficult problems.
- Prioritize long-term vision over quick wins.
- Build foundational "Dots" not just "Lines".
Topics
- Neuro-robotics
- Deep Tech Investment
- Startup Funding
- Biomedical Innovation
- Founder Profiles
Best for: Entrepreneur, Investor, Tech Journalist
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Sifted.